Reference Distributions for Alpha2-Macroglobulin: A Comparison of a Large Cohort to the World's Literature

Journal of Clinical Laboratory Analysis

Volumn 18, Issue 2, 2004, Pages 148-152

  Ritchie, Robert F ^a,b   Palomaki, Glenn E ^a   Neveux, Louis M ^a   Navolotskaia, Olga ^a  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

^b NONE   (United States)

Author keywords

Alpha2 macroglobulin; CRM 470 RPPHS; Meta analysis; Serum proteins

Indexed keywords

ALPHA 2 MACROGLOBULIN; PLASMA PROTEIN;

AGE; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HUMAN; LABORATORY TEST; MEASUREMENT; META ANALYSIS; PROGNOSIS; RELIABILITY; SERUM; SEX DIFFERENCE; ADOLESCENT; ADULT; AGED; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; ETHNIC GROUP; FEMALE; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; REFERENCE VALUE; REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-MACROGLOBULINS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 1842689242     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.20013     Document Type: Article

References (49)

1. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. Reference distributions for immunoglobulins A, G, and M: a comparison of a large cohort to the world's literature. J Lab Clin Anal 1998;12:371-377.
2. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. Reference distributions for the negative acute phase proteins, albumin, transferrin and transthyretin: a comparison of a large cohort to the world's literature. J Lab Clin Anal 1999;13:280-286.
3. 1-antitrypsin and haptoglobin: a comparison of a large cohort to the world's literature. Lab Clin Anal 2000;14:265-270.
4. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. Reference distributions for serum iron, total iron binding capacity and transferrin saturation: a comparison of a large cohort to the world's literature. J Lab Clin Anal 2002;16:246-252.
5. Ritchie RF, Palomaki GE, Navolotskaia O, Neveux LM, Ledue TB, Craig WY. Reference distributions for serum C3 and C4: a comparison of a single large cohort of reference values to the worlds literature. J Clin Lab Anal 18:139-147.
6. Whicher JT, Ritchie RF, Johnson AM, Baudner S, Bienvenu J, Blirup-Jensen S. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994;40:934-938.
7. Weiss WA. Normal values of specific serum proteins in children and adults. Klin Wochschr 1965;43:273.
8. James K, Taylor FB, Fudenberg HH. Trypsin stabilizers in human serum. The role of alpha-2-macroglobulin. Clin Chim Acta 1966;13:359-368.
9. Wilding P, Adham NF, Mehl JW, Haverback BJ. Alpha-2-macroglobulin concentrations in human serum. Nature 1967:214:1226-1227.
10. Cleve H, Alexander K, Mitzkat HJ, Nissen P, Salzmann I. Serum glycoproteins in diabetes mellitus: quantitative immunological determination of acid alpha 1-glycoprotein, Ge, alpha 2-macroglobulin and hemopexin in diabetics with and without angiopathy. Diabetologia 1968;4:48-55.
11. 2-globulin. Clin Chem 1970;16:925-930.
12. Song CS, Merkalz IR, Rifkind AB, Gillette PN, Kappas A. The influence of pregnancy and oral contraceptive steroids on the concentration of plasma proteins. Am J Obstet Gynecol 1970;106:227-231.
13. Mendenhall HW. Serum protein concentrations in pregnancy. Am J Obstet Gynecol 1970;106:388-399.
14. Laurell C-B, Jeppsson J-O. Protease inhibitors in plasma. In: Putnam F, editor. The plasma proteins. Structure, function and genetic control. Volume 1. New York: Academic Press; 1975. p 229-264.
15. Lyngbye J, Kroll J. Quantitative immunoelectrophoresis of proteins in serum from a normal population: season-, age-, and sex-related variations. Clin Chem 1971;17:495-500.
16. Weeke B, Krasilnikoff PA. The concentration of 21 serum proteins in normal children and adults. Acta Med Scand 1972;192:149-155.
17. Dotchev D, Liappis N, Hungerland H. Sex-specific differences of serum proteins in adults and influence of oral hormonal contraceptives on serum protein composition. Clin Chem Acta 1973;44:431-435.
18. Agostoni A, Marasini B, Stabilini R, Del Ninno E, Pontello M. Multivariate analysis of serum protein assays in chronic hepatitis and postnecrotic cirrhosis. Clin Chem 1974;20:428-429.
19. Brackertz D, Hagmann J, Keuppers F. Proteinase inhibitors in rheumatoid arthritis. Ann Rheum Dis 1975;34:225-230.
20. McBean LD, Smith JC Jr, Berne BH, Halsted JA. Serum zinc and alpha2-macroglobulin concentration in myocardial infarction, decubitus ulcer, multiple myeloma, prostatic carcinoma. Down's syndrome and nephrotic syndrome. Clin Chim Acta 1974;50: 43-51.
21. Barnett TB, Gottove D, Johnson AM. Protease inhibitors in chronic obstructive pulmonary disease. Am Rev Resp Dis 1975;111:587-593.
22. Svartman M, Potter EV, Poon-King T, Earle DP. Immunoglobins and complement components in synovial fluid of patients with acute rheumatic fever. J Clin Invest 1975;56: 111-117.
23. Hendrik M, Doeglas G, Bleumink E. Protease inhibitors in plasma of patients with chronic urticaria. Arch Dermatol 1975;111: 979-985.
24. Alkjaersig N, Fletcher A, Burstein R. Association between oral contraceptive use and thromboembolism: a new approach to its investigation based on plasma fibrinogen chromatography. Am J Obstet Gynecol 1975;122:199-211.
25. Snyder S, Durham BC, Iskandrian AS, Coodley EL, Linhart JW. Serum lipids and glycoproteins in acute myocardial infarction. Am Heart J 1975;90:582-586.
26. 2-macroglobulin: regulation and distribution. In: Rothchild M, Waldman T, editors. Plasma protein metabolism. Regulation of synthesis, distribution, and degradation. New York: Academic Press: 1970. p 427-436.
27. Statland BE, Winkel P, Killingsworth LM. Factors contributing to intra-individual day-to-day variation in concentrations of 10 specific proteins in sera of healthy subjects. Clin Chem 1976;22:1635-1638.
28. Nyulassy S, Hnilica P, Buc M, Guman M, Hirschova V, Š tefanovič J. Subacute (de Quervain's) thyroiditis: association with HLA-Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins. J Clin Endocrinol Metab 1977;45:270-274.
29. Pozzilli P, Tamburrano G, Mercalli ME, Javicoli M. Raised alpha-2-macroglobulin levels in acromegaly. Horm Metab Res 1978;10:359.
30. Ritchie RF. Serum protein profile analysis and interpretation: some basic information. Immunoassays in the clinical laboratory. New York: AR Liss, Inc., 1979: p 227-242.
31. Freer DE, Statland BE, Johnson M, Felton H. Reference values for selected enzyme activities and protein concentrations is serum and plasma derived from cord-blood specimens. Clin Chem 1979;25:565-569.
32. James K, Merriman J, Gray RS, Duncan LJ, Herd R. Serum alpha 2-macroglobulin in diabetes. J Clin Pathol 1980;33:163-166.
33. Pongpaew P, Schelp FP. Albumin, prealbumin, transferrin and serum proteinase inhibitors in asymptomatic and hospitalized Thai alcohol drinkers. J Stud Alcohol 1983;44:381-383.
34. Behr W, Schlimok G, Filchau V, Paul HA. Determination of reference intervals for 10 serum proteins measured by rate nephelometry, taking into consideration different sample groups and different distribution functions. J Clin Chem Clin Biochem 1985;23:157-166.
35. Ahlsten G, Tuvemo T, Gebre-Medhin M. Selected trace elements and proteins in serum of apparently healthy newborn infants of mothers who smoked during pregnancy. Acta Paediatr Scand 1989;78:671-676.
36. 1-protease inhibitor deficiency. Clin Chem 1989;35:1535-1537.
37. Raubenstine DA, Ballantine TVN, Greecher CP, Webb SL. Neonatal serum protein levels as indicators of nutritional status: normal values and correlation with anthropometric data. J Pediatr Gastroenterol Nutr 1990;10:53-61.
38. Winslet MC, Sherwell J, Radley S, Keighley MRB. The acute phase protein response in Crohn's colitis. Biochem Soc Trans 1991;19:222S.
39. Sveger T, Ohlsson K, Svenningsen N. Neonatal plasma concentrations of secretory leucocyte protease inhibitor. Acta Pediatr 1992;81:270-271.
40. Finotti P, Piccoli A, Varraro P. Alteration of plasma proteinase-antiproteinase system in type 1 diabetic patients. Influence of sex and relationships with metabolic control. Diabetes Res Clin Prac 1992;18:35-42.
41. Mohácsi A, Fülöp T Jr, Kozlovsky B, Hauck M, Kiss I, Leövey A. Sera and leukocyte elastase-type protease and antiprotease activity in healthy and atherosclerotic subjects of various ages. J Gerontol 1992;47:B154-B158.
42. Cliver SP, Goldenberg RL, Neel NR, Tamura T, Johnston KE, Hoffman HJ. Neonatal cord serum alpha 2-macroglobulin and fetal size at birth. Early Hum Dev 1993;33:201-206.
43. Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. J Lab Clin Med 1994;124: 118-124.
44. Kanakoudi F, Drossou V, Tzimouli V, et al. Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months. Clin Chem 1995;41:605-608.
45. Shiota G, Umeki K, Okano J-I, Kawasaki H. Hepatocyte growth factor and acute phase proteins in patients with chronic liver disease. J Med 1995;26:295-308.
46. de Sain-van der Velden MG, Rabelink TJ, Reijngoud DJ, et al. Plasma alpha 2 macroglobulin is increased in nephrotic patients as a result of increased synthesis alone. Kidney Int 1998;54:530-535.
47. Ritchie RF, Palomaki GE, Navolotskaia O, Neveux LM, Ledue TB, Craig WY. Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort. J Lab Clin Anal (in press).
48. National Committee for Clinical Laboratory Standards. How to define and determine reference intervals in the clinical laboratory: approved guideline. NCCLS Document C28-A. NCCLS: Villanova, PA: 1995.
49. Whicher, JW. Minutes of the International Federation of Clinical Chemistry meeting of the Committee on Plasma Proteins. Scientific Division, August 20, 1997, Basel, Switzerland and October 8, Viareggio, Italy, 1997.